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Summary Monoclonal antibodies directed against monomorphic determinants of Class I and Class II
products of the major histocompatibility complex (MHC) and against leucocyte differentiation antigens were
used in an indirect immunoperoxidase technique to compare their expression in normal and malignant disease
of the ovary, cervix and endometrium. MHC Class I products, strongly expressed on normal ovarian
epithelium, were uniformly absent from 7/8 ovarian carcinomas of varying histology. Lack of Class I
expression was also a feature of 6/10 cervical carcinomas and of 4/8 endometrial carcinomas, in comparison
with their repsective normal tissues. Relative to normal tissue epithelium MHC Class II products, could be
either lost or gained, the pattern ofexpression being either uniform or heterogeneous.
Leucocytes were sparse in normal ovary but more numerous in cervix and endometrium. In tumours, with
few exceptions, they were abundant, though usually confined to the stroma. T cells, largely of
cytotoxic/suppressor (OKT8) phenotype, tended to predominate though in some tumours, particularly cervical
carcinoma, large numbers of macrophages and to a lesser extent, B cells, were sometimes detected. By
contrast, leucocytes of natural killer (NK) phenotype were virtually non-existent in any tumour or normal
tissue.
The ingress of leucocytes into gynaecological neoplasms does not appear to be a random event and may be
evoked by an immune response against tumour-associated antigens. However, the relationship between in situ
mononuclear cell infiltration and MHC expression on epithelial tumour cells is complex and remains to be
elucidated.
It is now widely recognised that the biological
behaviour of tumours, which may differ markedly
for neoplasms of similar histopathological category
and grade, is determined to a significant extent by
interactions with neighbouring cells and by their
environment in general. Attempts to unravel the
critical factors in these complex in vivo interactions
have, in part, focussed on the relationship between
leucocyte infiltration and prognosis, for which,
there exists, at least for some neoplasms, a positive
correlation (Underwood, 1974; loachim, 1976) as
well as upon the anti-tumour properties in vitro of
inflammatory cells recovered from disaggregated
neoplasms (see Haskill, 1982; Moore, 1984; Vose &
Moore, 1985).
In the study of human tumours, only a limited
examination of the many parameters involved in
leucocyte ingress is presently feasible mainly
because the antigens expressed by these neoplasms
have only been partially defined. Of theoretical
relevance to host recognition of tumour cells in this
context, is the expression of products of the major
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histocompatibility complex (MHC). Class I (HLA-
A, B, C) antigens are found on virtually all normal
epithelial cells, and their recognition is essential for
the killing of virus-infected target cells (McMichael,
1978) by cytotoxic T lymphocytes and possibly of
tumour cells also. MHC Class II products were
until recently, considered to be restricted to cells of
the immune system, including B lymphocytes,
macrophages, vascular endothelial, dendritic and
other antigen presenting cells, as well as activated T
lymphocytes (Ko et al., 1979). Now in addition,
certain epithelia and a significant number of non-
lymphoid neoplasms including those of breast,
colorectal carcinoma and malignant melanoma are
known to display Class II molecules (Natali et al.,
1981; Thompson et al., 1982; Whitwell et al., 1984;
Daar & Fabre, 1983; Rognum et al., 1983).
Currently there is interest in whether this property
is a requirement for the induction of autologous
lymphoproliferative responses by tumour antigens
(Guerry et al., 1984).
The availability of McAbs to the framework
determinants of MHC Class I and Class II products
as well as to leucocyte differentiation antigens
permits simultaneous immunohistochemical analysis
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of the MHC status of tumour cells and the in situ
host response in a manner which has hitherto
proved impossible using conventional histological
techniques. In this study we extend this approach,
previously applied in this laboratory to breast and
colorectal carcinomas (Whitewell et al., 1984; Csiba
et al., 1984) to a comparison of neoplasms of the
cervix, endometrium and ovary, with their normal
tissue counterparts.
Patients and methods
Patients
Non-neoplastic cervical and endometrial tissues
were obtained from patients (aged 35-53 years)
undergoing total hysterectomy. The normality of
the tissues and their hormonal status were
confirmed by histological screening.
Normal ovarian tissue was generally obtained
from patients of menopausal age undergoing
hysterectomy at the time of the menopause, when
bilateral salpingo-oophorectomy is often routinely
carried out at the same time. The indications for
hysterectomy operations in this group were usually
abnormal bleeding or fibroids and the ages of the
patients ranged from 45-76 years. Specimens
judged histologically to have pathological changes
were discarded.
Endometrial carcinomas were likewise obtained
from hysterectomy specimens and cervical neo-
plasms from Wertheims hysterectomy specimens
and on one occasion by cervical biopsy. Patients
with cervical and endometrial carcinoma were aged
from 31-77 and 52-76 years respectively. Ovarian
tumours were obtained at laparotomy. The age
range of these patients was 50-69 years. Histo-
pathological data on each specimen are
incorporated into Tables II, III and IV.
Processing ofspecimens
Tissues were snap frozen within one hour of
surgical removal and stored over liquid nitrogen.
Serial sections (5-10 pm) were cut, mounted on
glass slides and air-dried. Each tissue was sampled
at three different planes, all three being mounted on
the same slide. When necessary, slides could be
stored at -20°C under dessicated conditions for up
to one month. Prior to staining, slides were
returned to room temperature, fixed in acetone for
5min, air-dried and immersed in 20% new born
calf serum in PBS, pH 7.5. Thereafter sections were
treated according to procedures previously
described from this laboratory (Whitwell et al.,
1984). Briefly, sections were incubated in the
monoclonal antibody (McAb) first layer, washed
and then exposed to diluted horse radish
peroxidase-conjugated rabbit anti-mouse Ig (Dako)
containing normal human serum. The peroxidase
reaction was developed in diaminobenzidine
containing freshly added H202, the sections washed
and counterstained in Gills No. 2 Haemalum and
mounted. The specificity of the McAbs was system-
atically checked on sections of palatine tonsil,
lymph node or spleen, against which new batches
of reagents were also titrated. No attempt was
made to abolish endogenous staining, which when
present, was readily distinguishable from specific
immunostaining. Tissue reactions were scored semi-
quantitatively (see footnote to Table II) as
previously described (Whitwell et al., 1984). In most
instances, morphometric analyses were precluded by
the intra-tissue variation across a given section.
Monoclonal antibodies (McAbs)
With the exception of the B73.1 reagent, details of
the McAbs used in this study have been given
previously (Whitwell et al., 1984; Csiba et al., 1984)
and are summarised in Table I.
Results
Clinicopathological and immunohistological data
on serial sections from normal tissues and
malignant tumours are summarised in Tables II
(ovary), III (cervix) and IV (endometrium) and
illustrative examples of specific immunostaining are
given in the Figures.
A feature common to all tissues examined was
the paucity of cells of NK phenotype. Only the
occasional B73.1+ or Leu 7 (HNK1)+ cell was
detected in a small minority of some 60 tissues
examined. This was so in malignant tumours
despite the often large increase in leucocytes over
normal tissues. B73.1+ cells were routinely
detectable in normal human spleen and Leu 7
(HNKI)+ cells in the germinal centres of lymphoid
tissue (posotive controls).
Normal ovary MHC Class I products (reactive
with 2A1) were invariably detectable on the
germinal epithelium, follicle lining cells and
endothelial cells and with much less staining
intensity on the scattered stromal cells.
MHC Class II products (reactive with TDR 31.1)
were also detectable on endothelial and follicle
lining cells but absent from epithelial and
connective tissue cells. Few DR+ leucocytes were
seen. 2D1 + leucocytes were evenly but sparsely
distributed throughout the ovarian stroma.
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Table I Monoclonal antibodies (McAbs) to major histocompatability complex (MHC) products and leucocyte
differentiation antigens
Ig classl
McAb (murine)b subclass Specificity Origin References
2A1 IgGI anti HLA Class I (HLA-A, -B, -C) P.C.L. Beverley Beverley, 1980.
TDR31.1 IgGi anti HLA Class II (HLA-DR) J. Bodmer DeKretser et al., 1982
2D1 IgGI Common leucocyte antigen P.C.L. Beverley Beverley et al., 1980
UCHT1 IgGI T cell receptor associated molecule P.C.L. Beverley Callard et al., 1981
(gp 19,000)
(This reagent possesses identical reactivity to OKT3). Kung et al., 1979
OKT4 IgG2b T helper/inducer subset Ortho Kung et al., 1979;
Reinherz et al., 1979a,b
OKT8 IgG2a T cytotoxic/suppressor subset Ortho Reinherz et al., 1980
OKMI IgG2b C3bi receptor (reactive with Ortho Breard et al., 1980
monocytes/macrophages; large
granular lymphocytes)
Leu 7 (HNKl) IgM Large granular lymphocytes (LGL): C.M. Balch Abo & Balch, 1981;
T cell subset Abo et al., 1982a.
MAS020 IgGl B cellsa Sera Lab. J. Habeshaw'
(personal communication)
B73.1 IgGl Large granular lymphocytes (LGL) G. Trinchieri (Perussia et al., 1983a,b)
(FcyR)
aReactive with inter- and intra-follicular B cells (determined on palatine tonsils) and probably reactive with a
polymorphic B cell determinant; bSecond layer reagent: Horse radish peroxidase conjugated rabbit anti-mouse Ig (Dako).
MAS020 suggested that, although few, the numbers
of T and B lymphocytes were approximately even,
with those of the OKT8 subset more frequently
detectable than those of the OKT4 subset.
Leucocytes were mainly associated with blood
vessels and follicles, and included some OKM1+
cells in a quarter of the tissues examined. In one
ovary containing a corpus luteum, the luteal cells
were stained with OKM1 and MAS020.
Interestingly, the epithelial cells of one benign
tumour (a serous cystadenomena) were positive for
both Class I and Class II products.
Ovarian carcinoma (Table II) Seven ovarian
carcinomas examined failed to express MHC Class
I products regardless of histological type or clinical
grade but stromal cells expressed the antigens
strongly. However, not all histological categories of
ovarian neoplasm were represented. Contrariwise,
4/8 carcinomas expressed DR antigens (Figures 1
and 2) where none wbre detectable in normal
epithelium. Staining was clearly associated with the
malignant cells where it was either uniform (Figure
1) or heterogeneous (Figure 2) although DR'
leucocytes (? B cells, monocytes, activated T cells)
were also detected in the stroma of many tumours.
Seven tumours were characterised by a massive
influx of 2D1+ leucocytes which was unrelated to
the degree of necrosis. While these were most
numerous in the stroma, in 6/8 specimens
leucocytes had also penetrated the tumour mass.
Comparison of staining with the various McAbs
indicated that the leucocyte stroma consisted of T
cells in excess of B cells and monocytes/
macrophages. OKT4+ cells were detectable in
6/8 samples and OKT8+ cells in 8/8. Overall,
OKT8+ cells obviously exceeded OKT4+ cells in
3/8 cases. All tumours contained OKM1 cells,
mostly in the stroma, but also in areas of tumour
necrosis.
Normal cervix MHC Class I antigens were
strongly expressed on the lower one-third to one
half of the squamous epithelium (Figure 3). In
10/14 samples endocervical glands were present,
which were Class I positive. There was no obvious
correlation with the hormonal status of the women.
MHC Class II antigens were indetectable on
epithelial cells but almost all tissues revealed a few
DR+ leucocytes scattered at the base of the
squamous epithelium and around the squamo-
columnar junction and endocervical glands. Seven
of 10 samples which contained endocervical glands
exhibited Class II staining of the glandular cells
which was again apparently unrelated to the
hormonal status of the women.
2D1+ leucocytes were present in moderate
numbers in 13/13 specimens. They were most
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Figure 1 Ovarian endometrioid adenocarcinoma
stained for MHC Class II (TDR 31.1) and showing
strong and uniform expression on the tumour cells,
but not on the supporting stroma. Counterstained with
haematoxylin ( x 220).
Al. ~ ~ ~ ~
Figure 3 Normal cervical squamous epithelium
stained for MHC Class I (2A1) showing pronounced
uniform expression in the lower one-third to one-half
of the squamous epithelium. Scattered leucocytes and
vessel lining cells in the sub-epithelial region are also
positive. Counterstained with haematoxylin ( x 220).
numerous at the base of the squamous epithelium
at the squamo-columnar junction and around endo-
cervical glands. They were also found scattered
throughout the lower half of the squamous
epithelium. Most of the 2D1 + populations were
also UCHTI+ indicating a predominance of T cells
(Figure 4) but not to the exclusion of other cell
types. OKT8 + cells were more consistently
demonstrable (12/12 tissues) and numerically
superior to OKT4 cells (detected in 8/13 tissues).
Eleven of 12 tissues contained MAS020+ cells,
albeit in low numbers around endocervical glands
which in most instances were also stained with this
reagent. OKM1+ cells were equally sparsely
represented in 9/14 tissues, with a slight excess at
the squamo-columnar junction.
Figure 2 Poorly differentiated ovarian adeno-
carcinoma stained for MHC Class II (TDR 31.1)
showing heterogeneity of expression among the
tumour cells. The supporting stromal tissue is negative
but contains some DR' leucocytes. Counterstained
with haematoxylin ( x 220).
.w -, * .4J. I
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Figure 4 Normal cervical squamous epithelium
stained for T lymphocytes (UCHTI) showing
numerous positive cells at the base and in the lower
half of the squamous epithelium, and in the underlying
connective tissue. Counterstained with haematoxylin
( x 220).
Cervical carcinoma (Table III) Six of 10 cervical
carcinomas failed to express MHC Class I antigens
(Figure 5). One (patient JS, Table III) exhibited
uniform 2A1 staining and three others (JC, SC, JH)
heterogeneous staining. Two carcinomas (patients
JC, SC) revealed DR positivity of the tumour cells.
All 10 carcinomas were massively infiltrated with
2D1 + leucocytes which had a predominantly
stromal localisation, though in 8 neoplasms there
was also significant penetration of the tumour
mass. Again, 2D1+ cell infiltration was not related
to tumour necrosis. Comparison with UCHTI
staining indicated that the majority of 2D1+ cells
were usually T cells with the OKT8 subset clearly
exceeding the OKT4 subset in 5/10 cases. However,
B cells (MAS020+) were present in the leucocytic556 A. FERGUSON et al.
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Figure 5 Cervical carcinoma stained for MHC Class I
(2A1) showing absence from the tumour cells in
contrast with positive expression on stromal and
endothelial cells. Counterstained with haematoxylin
(x220).
stroma in 8/10 specimens (in relatively large
numbers in five of these). In two cases this reagent
also stained the tumour cells. Nine of 10 samples
contained substantial numbers of OKM1 cells
mostly confined to the stroma but sometimes in
close juxtaposition to tumour cells (Figure 6).
Staining with OKM1 was also marked at the
necrotic centre of three neoplasms.
Normal endometrium Cells comprising the endo-
metrial glands, myometrial tissue, endothelium and
the stromal component of the endometrium were
uniformly 2A1+ and in 6/13 cases the endometrial
glands were also Class II positive. This latter
property was not related to the hormonal status of
the patients.
2D1+ leucocytes were present in moderate
numbers in all 13 tissues examined, a small
proportion of which were DR+. These were more
numerous in the endometrium than in the
underlying myometrium and tended to cluster
around the endometrial glands. The leucocytes
consisted predominantly of T cells of which
OKT8+ cells were more consistently detected (12/12
cases) than OKT4+ cells (9/13 cases). Ten of 12
specimens contained low numbers of B cells and
there were also few OKM1 cells. Some normal
endometrial glands were stained with Leu 7
(HNKI) and MAS020. There was little apparent
quantitative variation in the number and subtype of
leucocytes during the varying phases of the
menstrual cycle.
Endometrial carcinoma (Table IV) Four of 8
tumours were entirely lacking in MHC Class I
antigen and expression in 4 others was hetero-
geneous. Stromal tissue was strongly positive in all
*f A#4 .0 e.
Figure 6 Cervical carcinoma stained for monocytes/
macrophages (OKMI) showing numerous positive cells
within the tumour mass ( x220).
cases. There was no correlation between antigen
expression and tumour grade. Only 2/8 tumours
(patients BC and FH) expressed DR antigens on the
epithelial cells (cf. Figure 7); these tumours were
well differentiated and the pattern of staining was
heterogeneous.
2D1 + cells were present in large numbers in all 8
tumours examined. These were especially numerous
at the junctional areas between tumour and normal
tissue and in the tumour stroma. Five samples
showed significant penetration of the tumour mass.
Most of the 2D1 + leucocytes were T cells. Again,
in 4/8 samples OKT8+ cells were numerically
superior to OKT4+ cells. In this series, lymphocytes
which had penetrated the tumour mass were
predominantly of OKT8 phenotype (Figure 8) and
Figure 7 Endometrial adenocarcinoma stained for
MHC Class II (TDR 31.1) showing absence from the
tumour cells but positive expression on vessels and
leucocytes within the tumour mass. Also shown is an
area of architectural atypia adjacent to the tumour,
the staining pattern of which is heterogeneous.
Counterstained with haematoxylin ( x 220).
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Figure 8 Well differentiated adenocarcinoma ofendo- Figure 9 Adenocarcinoma of endometrium stained
metrium showing heavy ingress of suppressor/ for MHC Class II (TDR 31.1) showing numerous
cytotoxic (OKT8+) T cells. Counterstained with DR+ stromal leucocytes of lymphocyte and macro-
haematoxylin ( x 220). phage morphology, and DR- epithelial cells. Counter-
stained with haematoxylin (x 220).
DR' leucocytes which comprised macrophages as
well as lymphocytes (Figure 9). B cells were also
represented in moderate numbers in the stroma, but
were exceeded by cells of OKM1 + phenotype,
which were also detectable in the tumour mass (5/8
cases). In 4 of the 8 neoplasms, apparent cross-
reactivity with MAS020 of the most differentiated
tumour cells was in evidence. In addition, some
fibrous septal areas between endometrial tumour
masses were stained with Leu 7 (HNK1).
Discussion
While several tumour-associated antigens of gynae-
cological neoplasms have been detected serolo-
gically (Bast et al., 1983; Bhattacharya et al., 1982;
Masuho et al., 1984) their ability to evoke immune
responses in the autochthonous host is unknown.
Accordingly, attention was focussed on the MHC
products of tumour cells which are likely to be
involved in immune induction and tumour cell
recognition and the nature of the in situ
inflammatory cells as defined by monoclonal
antibodies. In respect of these properties this study
has disclosed a number of potentially important
differences between malignant gynaecological
tumours and their normal tissue counterparts. It is
preliminary to the extent that the panel of McAbs
was limited as were the numbers of tumours
examined ofeach ofthe major types.
Malignant epithelial cells were frequently MHC
Class I negative, under conditions where the stroma
was strongly positive. The difference from normal
tissue was most marked in the case of cervical and
ovarian carcinoma where the majority of tutmours
were negative. A trend towards Class I negativity
among endometrioid ovarian neoplasms was
reported by Kabawat et al. (1983). Our failure to
encounter Class I positive tumours in our smaller
series is thus probably a reflection of the
predominance of these histological types rather
than of differential staining sensitivity. To our
knowledge, the HLA Class I status of cervix and
endometrial carcinomas and their normal tissue
counterparts has not been previously reported (cf.
Daar et al., 1984a). Depressed or heterogeneous
expression of MHC Class I products, as detected
by immunohistological procedures, is a property of
some tumours of diverse histogenic derivation
including breast (Fleming et al., 1981; Bhan & Des
Marais, 1983; Rowe & Beverley, 1984; Whitwell et
al., 1984) and to a lesser extent, colorectal
carcinoma (Csiba et al., 1984). Other neoplasms,
notably malignant melanoma (Ruiter et al., 1982)
and certain histological categories of ovarian
carcinoma (Kabawat et al., 1983) appear to express
Class I antigens with greater consistency, a
phenomenon which is apparently related to the
predominantly T cell infiltrate which is a feature of
these tumours.
The level of the failure of primary tumours to
express Class I antigens has yet to be elucidated.
The immunoperoxidase method as employed in this
study is essentially a qualitative technique, so that
levels of Class I expression below the threshold
limits of detection, could conceivably occur, i.e. the
deficit may be relative, rather than absolute.
As exemplified by genetic experiments with
Daudi cells (Arce-Gomez et al., 1978) some
tumours may fail to express HLA due to lack of/2
microglobulin (/2i), the low molecular weight
glycoprotein required to stablize the Class I heavy
chain.
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The extent to which the gynaecological neo-
plasms in this study synthesised and secreted P2 m
was not ascertained. Failure to express MHC Class
I antigens by malignant cells arising from HLA-
positive tissues could, as Bodmer (1981) has
advocated, be a change that could be selected for
during tumour progression through the advantage
of resistance to attack by cytolytic T cells. Such
resistance might presumably only be an advantage
to tumours that express tumour-associated antigens
capable of evoking T cell immunity. However, this
hypothesis may now require some revision since, at
the clonal level, T cells lacking NK-like activity
may recognise certain tumour types in an immuno-
logically non-restricted fashion (De Vries & Spits,
1984). Thus, it may not be without significance in
our study that OKT8 + cell influx was not
correlated with HLA Class I status.
It is also possible that lack of Class I deter-
minants influences cell:cell interactions outside the
immune system in a way, e.g. that favours the
emergence of metastatic variants.
In common with other tissues, MHC Class II
molecules, normally considered to be confined to
cells of the immune system were frequently
detectable on the glandular epithelia of normal
cervix and endometrium (cf. Daar et al., 1984b).
The so-called 'aberrant expression' of Class II
products on normal epithelial cells is associated
with immunological, inflammatory as well as
hormonal stimuli (Klareskog et al., 1980; Lampert
et al., 1981; Mason et al., 1981; Selby et al., 1983)
and similar stimuli could promote their expression
on malignant epithelial cells.
In cervical and endometrial tumours MHC Class
II expression appears to reflect the cellular origin of
the neoplasm. On the other hand, tumours
originating from apparently DR-negative epithelium
(ovary) could acquire the ability to express Class II
molecules in response to stimuli of the type
mentioned above.
In both autoimmune and neoplastic diseases
MHC Class II products on target cells are
envisaged as a vehicle for the presentation of auto-
antigen to T helper/inducer lymphocytes on the
assumption that the configuration of the particular
Class II product fits that of the autoantigen
(Londei et al., 1984). In malignant melanoma, for
instance, autologous lymphoproliferative responses
can be induced by DR-positive tumour cells
(Guerry et al., 1984) but the extent to which similar
responses are evoked against other categories of
human malignancy has yet to be determined. In our
series, the four DR' ovarian tumours appeared to
show no excess T4 influx.
Analysis of the inflammatory infiltrates with
McAbs to leucocyte differentiation antigens con-
firmed that infiltration occurs, to a very marked
extent, in many gynaecological tumours. All
categories of leucocyte reactive with McAbs in this
series were increased in tumours in comparison
with normal tissues. The greatest contrast was in
carcinoma of the ovary, mainly because in the
normal tissue leucocytes were few. In normal
cervix where moderate numbers of leucocytes were
consistently detectable and were mostly T cells, the
greatest diference between normal and tumour
tissues was the increased number of B cells and
OKMI' macrophages. B cells were likewise present
in moderate numbers in ovarian and endometrial
carcinomas but not as numerous as in cervical
carcinoma, where their numbers sometimes
approached those of T cells. The extent to which
these had differentiated into plasma cells was not
easily discernible on cryostat sections.
Since OKM1 + cells could not always be
unequivocally identified as macrophages by
morphological criteria, and 80% of the large
granular lymphocyte (LGL) subset of peripheral
blood is OKM1+ (Ortaldo et al., 1981), the LGL
population was monitored in sections with two
McAbs, one of which (B73.1) is reactive with
virtually the entire LGL population (Perussia et al.,
1983a,b) and another (Leu 7; HNK1) which reacts
with approximately 75% of LGL as well as a
subset of T (suppressor) cells (Abo & Balch, 1981;
Abo et al., 1982a,b). B73.1+ or Leu 7+ cells were
scarcely ever seen, indicating that the OKM1 +
population was probably wholly of
monocyte/macrophage composition. In ovarian
cancer, there is marked size variation and cyto-
chemical heterogeneity among macrophages which
is associated with a spectrum of activities from
suppression to antibody-dependent cellular cyto-
toxicity (Haskill et al., 1982b). However, gynae-
cological cancers, like those of breast, colon and
lung (Watanabe et al., 1983; Bhan & Des Marais,
1983; Whitwell et al., 1984; Csiba et al., 1984),
contain few cells of natural killer phenotype.
This conclusion is in concordance with earlier
functional and morphological data on a variety of
tumours from several laboratories (Moore & Vose,
1981; Eremin et al., 1981; Pizzolo et al., 1984) and
on ovarian cancer, in particular (Introna et al.,
1983; Kabawat et al., 1983). The implications are
that NK cells, which are maximally expressed in
blood and spleen rarely extravasate and any direct
anti-tumour activity is consequently very limited or
non-existent.
The stimuli to leucocyte ingress into solid
neoplasms are still largely unknown though the
presumption remains that tumour antigenicity is a
major, but certainly not the only factor. Whether
human gynaecological neoplasms are immunogenicMHC PRODUCTS AND LEUCOCYTE ANTIGENS IN GYNAECOLOGICAL TUMOURS 561
in the autologous host or not, the demonstration
that the extravasation of leucocytes is not a random
event might be relevant to host reponses of an
immune nature. Although niopliometric analysis of
infiltrating populations is often complicated by
marked heterogeneity in a given section, it is clear
that some populations predominate over others. In
many sections, there was little doubt that T8+ cells
exceeded T4+ cells, indicative of a shift from the
proportions normally present in peripheral blood,
though perhaps to a lesser extent from those in
patients with progressive or advanced disease (cf.
McCluskey et al., 1983). Similarly as already noted,
in cervical carcinoma there was a significant ingress
of B cells which was not consistent with random
extravasation. However, it is possible that in certain
carcinomas (e.g. endometrial), the association of
T8+ lymphocytes with epithelial cells is not
indicative of a reaction to the tumour at all, but is
rather a reflection of the normal relationship
between the lymphocytes and epithelial cells in this
tissue.
Functional studies showing depressed prolifera-
tive activity in T cells recovered from ovarian
cancers implicated tumour inactivation as the cause,
or failure of a particular subset to localise at the
tumour site (Haskill et al., 1982a). An alternative
explanation might be that the predominant T8+
subset contains functionally active suppressor cells
(Vose & Moore, 1979). This possibility, which
would theoretically favour tumour growth, might
not be entirely unexpected in tumours which, apart
from therapeutic intervention, have 'escaped'
beyond recall as would doubtless have been the
case for the tumours in this study. At this point,
late in the progression of the lesions, the magnitude
and type of cellular immune response is likely to
have little in vivo operational significance to the
advantage of the host.
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